Hungary, Hungary

Istvan Puskas

This inventor holds 1 USPTO granted patent. Top assignee: Inqpharm Group Sdn Bhd. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Istvan Puskas. Retrieved from https://idiyas.com/inventor/istvan-puskas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Istvan Puskas: Innovator in Dietary Fat Reduction

Introduction

Istvan Puskas is a notable inventor from Hungary, recognized for his contributions to the field of dietary health. His innovative work focuses on reducing the absorption of dietary fat, which is crucial in combating obesity and related health issues.

Latest Patents

Puskas holds a patent for a composition aimed at reducing the absorption or bioavailability of lipids in the gastrointestinal tract. This invention involves a unique combination of dietary fiber and cyclodextrin, which together create a composition suitable for the prevention and treatment of obesity or hyperlipidaemia. His patent represents a significant advancement in dietary management and health improvement.

Career Highlights

Puskas is associated with Inqpharm Group Sdn Bhd, where he applies his expertise in developing health-related innovations. His work has garnered attention for its potential impact on public health, particularly in the area of obesity management.

Collaborations

Throughout his career, Puskas has collaborated with notable colleagues, including Thomas Hafner and Pee Win Chong. These partnerships have contributed to the development and refinement of his innovative compositions.

Conclusion

Istvan Puskas is a significant figure in the field of dietary health, with a focus on reducing fat absorption through innovative compositions. His work continues to influence the approach to obesity and hyperlipidaemia treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…